Home » news
news
new pharma bulletin
2011-12-21
new pharma bulletin
Convention against counterfeit medicines
2011-12-21
Convention against counterfeit medicines
Global expenditure on drugs will reach 1.1 trillion U.S. dollars by 2015, according IMS
2011-12-21
Global expenditure on drugs will reach 1.1 trillion U.S. dollars by 2015, according IMS
EGA will hold a forum for pharmacovigilance
2011-12-21
EGA will hold a forum for pharmacovigilance
State must stake on generic medicines. Interview of "Standard" newspaper with the Executive Director of BGPharmA, Mr. Rossen Kazakov
2009-01-08 ,
София
Today, the “Standard " newspaper published an interview with the Executive Director of BGPharmA, Mr. Rossen Kazakov, on the role of generic medicines to society. Mr. Kazakov stated in the interview…
The Executive Director of BGPharmA took part in a health show of Radio France International about the benefits of generic medicines
2008-12-23 ,
София
The Executive Director of BGPharmA, Rossen Kazakov, took part, on the 13th of December 2008 /Saturday /, in the Maria Cherneva`s health show of Radio France Internationale "And mostly health”.…
BGPharmA is against the applying of double standard to include medicines in the Positive list
2008-12-23 ,
София
BGPharmA disapproves the proposal, expressed on behalf of the PL Committee, that cheap medicines (eg below two BGN) should not be included in the Positive List. This would constitute a double standard…
БГФармА взе участие на кръгла маса, на която беше дискутирано финансирането на българското здравеопазване
2008-12-11 ,
София
Изпълнителният директор на БГФармА, Росен Казаков, взе участие на кръгла маса на тема „Реформи в „резерва”…
Current regulatory challenges for the medicinal products
2008-11-28 ,
София
The presentation of BGPharma from the Forum, held on 28th of November 2008 "Current regulatory challenges for Medicinal Products", organized by the Faculty of Public Health and Faculty of Pharmacy,…
EUROPEAN COMMISSION’S INQUIRY DISCLOSES BARRIERS TO RAPID ACCESS FOR
2008-11-28 ,
Brussels
DG Competition reports that delaying tactics by originator pharmaceutical companies cost society €3 billion. The EGA and the BGPharmA welcome the findings of the preliminary report on the sector…
